Maze Therapeutics secures $115 million in Series D funding to advance treatments for kidney and metabolic diseases with ...

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorization for Anzupgo ...

Danish drug developer Antag Therapeutics, which is pioneering novel treatments for obesity, today announced the closing of an 80 million euros ($83.8 million) Series A financing.

Roivant Sciences portfolio company Kinevant Sciences today revealed its Phase II study failed to show treatment benefit in ...

Atom Therapeutics partners with China Medical System to commercialize lingdolinurad for gout and hyperuricemia in China, Hong ...

US biopharma Olema Pharmaceuticals has announced a clinical trial collaboration and supply agreement with Swiss pharma giant ...

Japanese pharma major Takeda has agreed an exclusive licensing agreement with US pharma Keros Therapeutic to further develop, ...

The China-based subsidiary of French pharma major Sanofi revealed it has signed a memorandum of cooperation with Beijing ...

US privately-held biotech COUR Pharmaceuticals has entered into a strategic collaboration and licensing agreement with Roche ...

China's National Medical Products Administration (NMPA) has granted conditional approval for a combination therapy of Elunate ...

Senti Biosciences reports promising Phase I results for SENTI-202 in acute myeloid leukemia, with two of three patients ...

Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized neoantigen cancer immunotherapies ...